Publications Breadcrumb Home Publications Since we carefully research publications with DZIF affiliation before posting them on the DZIF website, there is usually a delay of two to three months between a paper's publication date and its listing on the DZIF publications website. Show filterHide filter All years of publication All years of publication20122013201420152016201720182019202020212022202320242025 All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyClinical Trial UnitProduct Development Feb 2022 Cell Rep SARS-CoV-2 variants of concern display enhanced intrinsic pathogenic properties and expanded organ tropism in mouse models Autoren Stolp B et al. Feb 2022 J Chem Inf Model Characterization of an Allosteric Pocket in Zika Virus NS2B-NS3 Protease Autoren Santos NP et al. Feb 2022 Viruses High-Throughput Platform for Detection of Neutralizing Antibodies Using Flavivirus Reporter Replicon Particles Autoren Lücke AC et al. Feb 2022 Comput Struct Biotechnol J Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing Autoren Luedemann M et al. Feb 2022 J Bacteriol NamZ1 and NamZ2 from the oral pathogen Tannerella forsythia are peptidoglycan processing exo-β-N-acetylmuramidases with distinct substrate specificity Autoren Borisova M et al. Feb 2022 Proc Natl Acad Sci U S A Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection Autoren Schuhenn J et al. Feb 2022 Clin Microbiol Infect Neutralizing antibody activity against the B.1.617.2 (delta) variant 8 months after two-dose vaccination with BNT162b2 in health care workers Autoren Benning L et al. Feb 2022 J Viral Hepat Soluble inflammatory mediators identify HCV patients who may be cured with four weeks of antiviral treatment Autoren Khera T et al. Feb 2022 JHEP Rep A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection Autoren Burm R et al. Feb 2022 Eur J Clin Microbiol Infect Dis Fosfomycin as a salvage therapy for treating urinary tract infections due to multidrug-resistant Escherichia coli Autoren Nordmann P et al. Feb 2022 Front Immunol Interleukin-27 in Tuberculosis: A Sheep in Wolf's Clothing? Autoren Ritter K Rousseau J Hölscher C Feb 2022 Anal Bioanal Chem Light contamination in stable isotope-labelled internal peptide standards is frequent and a potential source of false discovery and quantitation error in proteomics Autoren Salek M et al. Feb 2022 Sci Rep Advanced sequencing approaches detected insertions of viral and human origin in the viral genome of chronic hepatitis E virus patients Autoren Papp CP et al. Feb 2022 Adv Healthc Mater Nano-in-Microparticles for Aerosol Delivery of Antibiotic-Loaded, Fucose-Derivatized, and Macrophage-Targeted Liposomes to Combat Mycobacterial Infections: In Vitro Deposition, Pulmonary Barrier Interactions, and Targeted Delivery Autoren Huck BC et al. Feb 2022 Life Sci Alliance Proteomic landscape of SARS-CoV-2- and MERS-CoV-infected primary human renal epithelial cells Autoren Kohli A et al. Feb 2022 Anal Chem Fully Automated Chemiluminescence Microarray Analysis Platform for Rapid and Multiplexed SARS-CoV-2 Serodiagnostics Autoren Klüpfel J et al. Feb 2022 Clin Transl Immunology Genome-wide off-target analyses of CRISPR/Cas9-mediated T-cell receptor engineering in primary human T cells Autoren Käuferle T et al. Feb 2022 mSystems Incidence of an Intracellular Multiplication Niche among Acinetobacter baumannii Clinical Isolates Autoren Rubio T et al. Feb 2022 Signal Transduct Target Ther NK cell dysfunction in severe COVID-19: TGF-β-induced downregulation of integrin beta-2 restricts NK cell cytotoxicity Autoren Barros-Martins J Förster R Bošnjak B Feb 2022 ChemMedChem Andrographolide Derivatives Target the KEAP1/NRF2 Axis and Possess Potent Anti-SARS-CoV-2 Activity Autoren Schulte B et al. Feb 2022 Front Cell Infect Microbiol Boromycin has Rapid-Onset Antibiotic Activity Against Asexual and Sexual Blood Stages of Plasmodium falciparum Autoren de Carvalho LP et al. Feb 2022 Nephrol Dial Transplant Heterologous immunization with BNT162b2 followed by mRNA-1273 in dialysis patients: seroconversion and presence of neutralizing antibodies Autoren Kohmer N et al. Feb 2022 Lancet Microbe The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries Autoren Hoenigl M et al. Jan 2022 Emerg Infect Dis Infection Control Measures and Prevalence of SARS-CoV-2 IgG among 4,554 University Hospital Employees, Munich, Germany Autoren Erber J et al. Jan 2022 Lancet Infect Dis Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases Autoren Lange C et al. Pagination Previous page ‹‹ Seite 30 Seite 31 Seite 32 Seite 33 Seite 34 Current page 35 Seite 36 Seite 37 Seite 38 Seite 30 Seite 31 Seite 32 Seite 33 Seite 34 Seite 35 Seite 36 Seite 37 Seite 38 Next page ››
Feb 2022 Cell Rep SARS-CoV-2 variants of concern display enhanced intrinsic pathogenic properties and expanded organ tropism in mouse models Autoren Stolp B et al.
Feb 2022 J Chem Inf Model Characterization of an Allosteric Pocket in Zika Virus NS2B-NS3 Protease Autoren Santos NP et al.
Feb 2022 Viruses High-Throughput Platform for Detection of Neutralizing Antibodies Using Flavivirus Reporter Replicon Particles Autoren Lücke AC et al.
Feb 2022 Comput Struct Biotechnol J Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing Autoren Luedemann M et al.
Feb 2022 J Bacteriol NamZ1 and NamZ2 from the oral pathogen Tannerella forsythia are peptidoglycan processing exo-β-N-acetylmuramidases with distinct substrate specificity Autoren Borisova M et al.
Feb 2022 Proc Natl Acad Sci U S A Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection Autoren Schuhenn J et al.
Feb 2022 Clin Microbiol Infect Neutralizing antibody activity against the B.1.617.2 (delta) variant 8 months after two-dose vaccination with BNT162b2 in health care workers Autoren Benning L et al.
Feb 2022 J Viral Hepat Soluble inflammatory mediators identify HCV patients who may be cured with four weeks of antiviral treatment Autoren Khera T et al.
Feb 2022 JHEP Rep A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection Autoren Burm R et al.
Feb 2022 Eur J Clin Microbiol Infect Dis Fosfomycin as a salvage therapy for treating urinary tract infections due to multidrug-resistant Escherichia coli Autoren Nordmann P et al.
Feb 2022 Front Immunol Interleukin-27 in Tuberculosis: A Sheep in Wolf's Clothing? Autoren Ritter K Rousseau J Hölscher C
Feb 2022 Anal Bioanal Chem Light contamination in stable isotope-labelled internal peptide standards is frequent and a potential source of false discovery and quantitation error in proteomics Autoren Salek M et al.
Feb 2022 Sci Rep Advanced sequencing approaches detected insertions of viral and human origin in the viral genome of chronic hepatitis E virus patients Autoren Papp CP et al.
Feb 2022 Adv Healthc Mater Nano-in-Microparticles for Aerosol Delivery of Antibiotic-Loaded, Fucose-Derivatized, and Macrophage-Targeted Liposomes to Combat Mycobacterial Infections: In Vitro Deposition, Pulmonary Barrier Interactions, and Targeted Delivery Autoren Huck BC et al.
Feb 2022 Life Sci Alliance Proteomic landscape of SARS-CoV-2- and MERS-CoV-infected primary human renal epithelial cells Autoren Kohli A et al.
Feb 2022 Anal Chem Fully Automated Chemiluminescence Microarray Analysis Platform for Rapid and Multiplexed SARS-CoV-2 Serodiagnostics Autoren Klüpfel J et al.
Feb 2022 Clin Transl Immunology Genome-wide off-target analyses of CRISPR/Cas9-mediated T-cell receptor engineering in primary human T cells Autoren Käuferle T et al.
Feb 2022 mSystems Incidence of an Intracellular Multiplication Niche among Acinetobacter baumannii Clinical Isolates Autoren Rubio T et al.
Feb 2022 Signal Transduct Target Ther NK cell dysfunction in severe COVID-19: TGF-β-induced downregulation of integrin beta-2 restricts NK cell cytotoxicity Autoren Barros-Martins J Förster R Bošnjak B
Feb 2022 ChemMedChem Andrographolide Derivatives Target the KEAP1/NRF2 Axis and Possess Potent Anti-SARS-CoV-2 Activity Autoren Schulte B et al.
Feb 2022 Front Cell Infect Microbiol Boromycin has Rapid-Onset Antibiotic Activity Against Asexual and Sexual Blood Stages of Plasmodium falciparum Autoren de Carvalho LP et al.
Feb 2022 Nephrol Dial Transplant Heterologous immunization with BNT162b2 followed by mRNA-1273 in dialysis patients: seroconversion and presence of neutralizing antibodies Autoren Kohmer N et al.
Feb 2022 Lancet Microbe The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries Autoren Hoenigl M et al.
Jan 2022 Emerg Infect Dis Infection Control Measures and Prevalence of SARS-CoV-2 IgG among 4,554 University Hospital Employees, Munich, Germany Autoren Erber J et al.
Jan 2022 Lancet Infect Dis Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases Autoren Lange C et al.
